Walleye Capital’s Hims & Hers Health HIMS Stock Holding History

Walleye Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.42M	Sell	185,200 -54,600	-23%	-$1.47M	0.02%	691
2026 Q1	$4.98M	Buy	239,800 +112,600	+89%	+$2.66M	0.02%	806
2025 Q4	$4.13M	Sell	127,200 -115,000	-47%	-$4.93M	0.01%	1291
2025 Q3	$13.7M	Buy	242,200 +45,600	+23%	+$2.34M	0.05%	403
2025 Q2	$9.8M	Buy	196,600 +147,000	+296%	+$6.64M	0.04%	506
2025 Q1	$1.47M	Sell	49,600 -114,800	-70%	-$4.26M	0.01%	1675
2024 Q4	$3.98M	Buy	164,400 +83,100	+102%	+$2.06M	0.01%	1242
2024 Q3	$1.5M	Sell	81,300 -29,600	-27%	-$530K	﹤0.01%	2237
2024 Q2	$2.24M	Buy	110,900 +84,500	+320%	+$1.41M	﹤0.01%	1997
2024 Q1	$408K	Buy	26,400 +4,700	+22%	+$53K	﹤0.01%	3376
2023 Q4	$193K	Buy	21,700 +9,100	+72%	+$67.3K	﹤0.01%	3699
2023 Q3	$79.3K	Sell	12,600 -22,900	-65%	-$170K	﹤0.01%	4032
2023 Q2	$334K	Sell	35,500 -13,200	-27%	-$131K	﹤0.01%	2716
2023 Q1	$483K	Buy	+48,700	New	+$427K	0.01%	1746

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Walleye Capital's HIMS Position: Q2 2026 in Review

Walleye Capital reduced its Hims & Hers Health (HIMS) stake by 92% in Q2 2026, selling an estimated $8.08M and leaving 24,878 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Walleye Capital first reported a position in HIMS in Q1 2020 and has held it in 20 quarters since. The position peaked at $12.3M in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Walleye Capital held 24,878 shares of Hims & Hers Health worth $863K as of Q2 2026.
Walleye Capital sold 300,875 Hims & Hers Health shares in Q2 2026, an estimated $8.08M.
Hims & Hers Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2254 holding.
Walleye Capital first reported a position in Hims & Hers Health in Q1 2020 and has held it in 20 quarters since.
Walleye Capital's Hims & Hers Health position peaked at $12.3M in Q4 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.